As of 2025-12-27, the Relative Valuation of Aerie Pharmaceuticals Inc (AERI) is (15.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of Aerie Pharmaceuticals Inc based on Relative Valuation is -198.7%.
The range of the Relative Valuation is (14.59) - (15.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 20.5x | 19.9x |
| Forward P/E multiples | 19.7x - 21.5x | 20.8x |
| Fair Price | (14.59) - (15.16) | (15.05) |
| Upside | -195.7% - -199.4% | -198.7% |
| Date | P/E |